Wealth Enhancement Trust Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.16M Sell
5,971
-751
-11% -$767K 0.8% 32
2026
Q1
$6.18M Sell
6,722
-410
-6% -$416K 0.75% 32
2025
Q4
$7.66M Buy
+7,132
New +$6.82M 0.97% 24

Other funds holding LLY

Wealth Enhancement Trust Services's LLY Position: Q2 2026 in Review

Wealth Enhancement Trust Services reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $767K and leaving 5,971 shares worth $7.16M. The position accounts for 0.8% of the portfolio, ranked #32.

Wealth Enhancement Trust Services first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.66M in Q4 2025. 3,701 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Enhancement Trust Services held 5,971 shares of Eli Lilly worth $7.16M as of Q2 2026.
  • Wealth Enhancement Trust Services sold 751 Eli Lilly shares in Q2 2026, an estimated $767K.
  • Eli Lilly made up 0.8% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #32 holding.
  • Wealth Enhancement Trust Services first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Wealth Enhancement Trust Services's Eli Lilly position peaked at $7.66M in Q4 2025.
  • 3,701 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.